Description
IMODIUM ZAPID offers effective relief for those experiencing acute diarrhea, providing a convenient solution with its orodispersible tablet form. Each tablet contains 2 mg of loperamide hydrochloride, designed to dissolve effortlessly on the tongue without the need for water, making it an ideal choice for on-the-go relief.
Key Benefits
- Fast-Acting Relief: Specifically formulated to address symptoms of acute diarrhea, including traveler's diarrhea and irritable bowel syndrome in individuals aged 12 and older.
- Convenient Formulation: The unique dissolving tablet ensures ease of use, requiring no water, which enhances practicality during travel or outdoor activities.
Usage Instructions
- Initial Dosage: Begin with 2 tablets, followed by 1 tablet after each loose stool if necessary.
- Maximum Dosage: Do not exceed 8 tablets within a 24-hour period and avoid use beyond 48 hours without consulting a healthcare professional.
Mechanism of Action
Loperamide works by targeting μ-opioid receptors in the gut, reducing muscle contractions and slowing intestinal transit. This action helps restore normal bowel function and can also be beneficial in reducing ileostomy output.
Precautions
- Not Suitable For: Children under 12, individuals with certain medical conditions such as acute ulcerative colitis, and those with hypersensitivity to loperamide.
- Blister Pack Integrity: Ensure the blister foil is intact before use.
- Potential Side Effects: May include drowsiness, dizziness, and constipation. Users are advised to seek medical advice if symptoms persist or if dehydration is suspected.
Important Warnings
- Cardiac Risks: High doses can lead to serious cardiac side effects. Use with caution, particularly in individuals with liver impairment or older adults.
- Pregnancy and Breastfeeding: Not recommended during breastfeeding and should be used with caution during pregnancy.
Common Side Effects
- Constipation
- Nausea
- Headache
- Abdominal cramps
Serious Side Effects
- Severe allergic reactions
- Cardiac arrhythmias
- Toxic megacolon
Drug Interactions
Significant interactions may occur with P-glycoprotein inducers/inhibitors and CYP3A4 inhibitors. It is metabolized in the liver and primarily excreted in feces.
Additional Information
Always read the label and adhere to the usage instructions. For a comprehensive list of side effects, refer to the leaflet included with the medication. This product aims to provide reliable relief while ensuring user safety through clear guidelines and warnings.